Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A phase III, randomized, open-label, multicenter study of the safety and efficacy of efavirenz versus tenofovir when administered in combination with the abacavir/lamivudine fixed-dose combination tablet as a once-daily regimen in antiretroviral-naive HIV-1 infected subjects.
abacavir/lamivudine
ESS30009
NCT00053638
Infection, Human Immunodeficiency Virus I
Phase 3
 
January 2014

Powered by ideaPoint, Inc.